Concepedia
Statistics
Publications
20
Citations
790
H-Index
16
Active since
1999
Affiliations
Weizmann Institute of Science(Current)
Hadassah Medical Center
Hebrew University of Jerusalem
Barzilai Medical Center
Compugen (Israel)
Arthur Machlenkin is an author at Weizmann Institute of Science specializing in oncology, immunology, and cancer immunology.
Publications per year
1999–2019
1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage.
Amiram Ravid, Dafna Rocker, Arthur Machlenkin et al. · PubMed · 1999 · 161 citations
Medicine, Oncology, Pharmacology +14
Combined Dendritic Cell Cryotherapy of Tumor Induces Systemic Antimetastatic Immunity
Arthur Machlenkin, Ofir Goldberger, Boaz Tirosh et al. · Clinical Cancer Research · 2005 · 115 citations
Life Sciences, Immunology, Oncology +17
Human CTL Epitopes Prostatic Acid Phosphatase-3 and Six-Transmembrane Epithelial Antigen of Prostate-3 as Candidates for Prostate Cancer Immunotherapy
Arthur Machlenkin, Adrian Paz, Erez Bar Haim et al. · Cancer Research · 2005 · 75 citations
Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity
Benjamin Murter, Xiaoyu Pan, Eran Ophir et al. · Cancer Immunology Research · 2019 · 57 citations · Full text
Capture of Tumor Cell Membranes by Trogocytosis Facilitates Detection and Isolation of Tumor-Specific Functional CTLs
Arthur Machlenkin, Ronny Uzana, Shoshana Frankenburg et al. · Cancer Research · 2008 · 42 citations · Full text
1–5 of 20